MetaADEDB 2.0 @ LMMD
N-(4-bromo-2-fluorophenyl)-6-methoxy-7-((1-methylpiperidin-4-yl)methoxy)quinazolin-4-amine
(UHTHHESEBZOYNR-UHFFFAOYSA-N)
Structure
SMILES
COc1cc2c(ncnc2cc1OCC1CCN(CC1)C)Nc1ccc(cc1F)Br
Type(s)
Approved
ATC code(s)
L01XE12
Molecular Formula:
C22H24BrFN4O2
Molecular Weight:
475.354
Log P:
5.0151
Hydrogen Bond Acceptor:
5
Hydrogen Bond Donor:
1
TPSA:
59.51
CAS Number(s):
338992-00-0; 443913-73-3
Synonym(s)
1.
N-(4-bromo-2-fluorophenyl)-6-methoxy-7-((1-methylpiperidin-4-yl)methoxy)quinazolin-4-amine
2.
ZD 6474
3.
ZD-6474
4.
ZD6474
5.
Zactima
6.
caprelsa
7.
vandetanib
External Link(s)
MeSHC452423
PubChem Compound3081361
BindingDB50331097
4655
21
ChEBI49960
CHEMBLCHEMBL24828
DrugBankDB05294
DrugCentral4178
IUPHAR/BPS Guide to PHARMACOLOGY5717
KEGGdr:D06407
Therapeutic Target DatabaseD0G6QF
ZINC53683345
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1FatigueFAERS: 25
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
2NauseaFAERS: 20SIDER
US FAERS
3Disease ProgressionFAERS: 17US FAERS
4AcneFAERS: 15SIDER
US FAERS
5ArthralgiaFAERS: 10SIDER
US FAERS
6EpistaxisFAERS: 10SIDER
US FAERS
7ErythemaFAERS: 9
Canada Vigilance: 1
Canada Vigilance
US FAERS
8Blood calcitonin increasedFAERS: 8US FAERS
9HeadacheFAERS: 8SIDER
US FAERS
10PneumoniaFAERS: 8SIDER
US FAERS
11Blood creatinine increasedFAERS: 7SIDER
US FAERS
12DehydrationFAERS: 7SIDER
US FAERS
13DizzinessFAERS: 7SIDER
US FAERS
14Dry skinFAERS: 7SIDER
US FAERS
15AstheniaFAERS: 6SIDER
US FAERS
16Carcinoembryonic antigen increasedFAERS: 6US FAERS
17Drug ineffectiveFAERS: 6US FAERS
18PruritusFAERS: 6SIDER
US FAERS
19Abdominal PainFAERS: 5SIDER
US FAERS
20Dermatitis acneiformFAERS: 5SIDER
US FAERS
21Malignant neoplasm progressionFAERS: 5US FAERS
22Pulmonary EmbolismFAERS: 5US FAERS
23StomatitisFAERS: 5SIDER
US FAERS
24Urinary tract infectionFAERS: 5SIDER
US FAERS
25Adverse eventFAERS: 4US FAERS
26Blood thyroid stimulating hormone increasedFAERS: 4US FAERS
27Joint swellingFAERS: 4US FAERS
28MalaiseFAERS: 4US FAERS
29PainFAERS: 4SIDER
US FAERS
30Skin toxicityFAERS: 4US FAERS
31Abdominal discomfortFAERS: 3US FAERS
32Aspartate Aminotransferase IncreasedFAERS: 3US FAERS
33Chest discomfortFAERS: 3US FAERS
34ColitisFAERS: 3SIDER
US FAERS
35Electrocardiogram QT interval abnormalFAERS: 3US FAERS
36Electrocardiogram repolarisation abnormalityFAERS: 3US FAERS
37ErythrosisFAERS: 3US FAERS
38Lymphocyte count decreasedFAERS: 3US FAERS
39PneumonitisFAERS: 3US FAERS
40Respiratory FailureFAERS: 3SIDER
US FAERS
41SepsisFAERS: 3SIDER
US FAERS
42TachycardiaFAERS: 3US FAERS
43Weight decreasedFAERS: 3SIDER
US FAERS
44AbasiaFAERS: 2US FAERS
45Acute kidney injuryFAERS: 2US FAERS
46Alanine Aminotransferase IncreasedFAERS: 2SIDER
US FAERS
47Atrioventricular BlockFAERS: 2US FAERS
48Blood calcitonin decreasedFAERS: 2US FAERS
49Blood glucose decreasedFAERS: 2SIDER
US FAERS
50Burning sensationFAERS: 2US FAERS
51CataractFAERS: 2SIDER
US FAERS
52Cerebrovascular accidentFAERS: 2US FAERS
53Chest PainFAERS: 2SIDER
US FAERS
54ChillsFAERS: 2US FAERS
55DermatitisFAERS: 2SIDER
US FAERS
56DiverticulitisFAERS: 2SIDER
US FAERS
57DysgeusiaFAERS: 2SIDER
US FAERS
58DysuriaFAERS: 2SIDER
US FAERS
59Electrocardiogram abnormalFAERS: 2US FAERS
60Eye painFAERS: 2US FAERS
61General physical health deteriorationFAERS: 2SIDER
US FAERS
62HypersensitivityFAERS: 2US FAERS
63Hypertensive crisisFAERS: 2SIDER
US FAERS
64HypotensionFAERS: 2US FAERS
65Impaired work abilityFAERS: 2US FAERS
66Intestinal PerforationFAERS: 2SIDER
US FAERS
67LeukopeniaFAERS: 2US FAERS
68Limb injuryFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
69Lip swellingFAERS: 2US FAERS
70Memory impairmentFAERS: 2US FAERS
71Muscle tightnessFAERS: 2US FAERS
72Musculoskeletal chest painFAERS: 2US FAERS
73NephrolithiasisFAERS: 2SIDER
US FAERS
74Oral painFAERS: 2US FAERS
75Oropharyngeal painFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
76Peripheral swellingFAERS: 2US FAERS
77PeritonitisFAERS: 2SIDER
US FAERS
78Renal tubular disorderFAERS: 2US FAERS
79RestlessnessFAERS: 2US FAERS
80Skin WrinklingFAERS: 2US FAERS
81SunburnFAERS: 2US FAERS
82SyncopeFAERS: 2US FAERS
83UrticariaFAERS: 2US FAERS
84Visual ImpairmentFAERS: 2SIDER
US FAERS
85VomitingFAERS: 2SIDER
US FAERS
86AbscessFAERS: 1US FAERS
87AmnesiaFAERS: 1US FAERS
88Angina PectorisFAERS: 1US FAERS
89AnuriaFAERS: 1SIDER
US FAERS
90AphagiaFAERS: 1US FAERS
91AphasiaFAERS: 1US FAERS
92Arterial thrombosisFAERS: 1US FAERS
93AscitesFAERS: 1US FAERS
94Atrial FibrillationFAERS: 1SIDER
US FAERS
95Biliary dilatationFAERS: 1US FAERS
96Blood creatine increasedFAERS: 1US FAERS
97Blood creatinine decreasedFAERS: 1US FAERS
98Blood glucose increasedFAERS: 1SIDER
US FAERS
99Blood potassium decreasedFAERS: 1SIDER
US FAERS
100Blood thyroid stimulating hormone decreasedFAERS: 1US FAERS
101Blood urea increasedFAERS: 1US FAERS
102Blood urine presentFAERS: 1US FAERS
103Bone abscessFAERS: 1US FAERS
104Bone painFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
105Carcinoembryonic antigen decreasedFAERS: 1US FAERS
106Cardiac ArrestFAERS: 1SIDER
US FAERS
107CardiotoxicityFAERS: 129630634CTD
US FAERS
108CellulitisFAERS: 1SIDER
US FAERS
109Central nervous system lesionFAERS: 1US FAERS
110ConjunctivochalasisFAERS: 1US FAERS
111ConstipationFAERS: 1SIDER
US FAERS
112Cornea verticillataFAERS: 1US FAERS
113Corneal dystrophyFAERS: 1US FAERS
114Creatinine renal clearance decreasedFAERS: 1US FAERS
115Depressed moodFAERS: 1US FAERS
116DiscomfortFAERS: 1US FAERS
117Diverticular perforationFAERS: 1US FAERS
118Drug dose omissionFAERS: 1US FAERS
119Drug effect incompleteFAERS: 1US FAERS
120DyspepsiaFAERS: 1SIDER
US FAERS
121Ear discomfortFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
122Electrocardiogram PQ interval prolongedFAERS: 1US FAERS
123Electrocardiogram changeFAERS: 1US FAERS
124EnterocolitisFAERS: 1US FAERS
125Exfoliative rashFAERS: 1US FAERS
126Extremity necrosisFAERS: 1US FAERS
127Eye irritationFAERS: 1US FAERS
128FibrosisFAERS: 1US FAERS
129FolliculitisFAERS: 1SIDER
US FAERS
130Full blood count decreasedFAERS: 1US FAERS
131Gamma-Glutamyltransferase IncreasedFAERS: 1US FAERS
132Gastric ulcerFAERS: 1US FAERS
133Gastrointestinal perforationFAERS: 1US FAERS
134Gene MutationFAERS: 1US FAERS
135GingivitisFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
136Guillain-Barre SyndromeFAERS: 1US FAERS
137HordeolumFAERS: 1US FAERS
138HydrocephalusFAERS: 1US FAERS
139HypoparathyroidismFAERS: 1US FAERS
140HypothyroidismFAERS: 1SIDER
US FAERS
141IleusFAERS: 1SIDER
US FAERS
142InfectionFAERS: 1SIDER
US FAERS
143Infectious colitisFAERS: 1US FAERS
144Intentional drug misuseFAERS: 1US FAERS
145KeratopathyFAERS: 1SIDER
US FAERS
146Large intestine perforationFAERS: 1US FAERS
147Lens dislocationFAERS: 1US FAERS
148Lower respiratory tract infectionFAERS: 1US FAERS
149Lung AbscessFAERS: 1US FAERS
150Lung cystFAERS: 1US FAERS
151LymphadenopathyFAERS: 1US FAERS
152LymphopeniaFAERS: 1US FAERS
153Malignant HypertensionFAERS: 1SIDER
US FAERS
154MalnutritionFAERS: 1SIDER
US FAERS
155Mental impairmentFAERS: 1US FAERS
156MetrorrhagiaFAERS: 1US FAERS
157Monocyte count increasedFAERS: 1US FAERS
158Musculoskeletal PainFAERS: 1US FAERS
159Musculoskeletal discomfortFAERS: 1SIDER
US FAERS
160MyalgiaFAERS: 1US FAERS
161MydriasisFAERS: 1US FAERS
162MyocarditisFAERS: 1US FAERS
163OliguriaFAERS: 1US FAERS
164OnychoclasisFAERS: 1US FAERS
165Oral candidiasisFAERS: 1US FAERS
166PalpitationsFAERS: 1US FAERS
167Pancreatic carcinomaFAERS: 1US FAERS
168PancreatitisFAERS: 1SIDER
US FAERS
169Pericardial effusionFAERS: 1US FAERS
170Peripheral embolismFAERS: 1US FAERS
171Personality ChangeFAERS: 1US FAERS
172PetechiaeFAERS: 1US FAERS
173PhotophobiaFAERS: 1US FAERS
174PolydipsiaFAERS: 1US FAERS
175PolyuriaFAERS: 1US FAERS
176Pregnancy of partnerFAERS: 1US FAERS
177Procedural complicationFAERS: 1US FAERS
178Product label issueFAERS: 1US FAERS
179Product supply issueFAERS: 1US FAERS
180Product use in unapproved indicationFAERS: 1US FAERS
181Product use issueFAERS: 1US FAERS
182ProteinuriaFAERS: 1SIDER
US FAERS
183PyelonephritisFAERS: 1SIDER
US FAERS
184RalesFAERS: 1US FAERS
185Rectal abscessFAERS: 1US FAERS
186Respiratory tract inflammationFAERS: 1US FAERS
187RetchingFAERS: 1US FAERS
188Secondary hypertensionFAERS: 1US FAERS
189Sinus TachycardiaFAERS: 1US FAERS
190Sinus bradycardiaFAERS: 1US FAERS
191Skin PapillomaFAERS: 1US FAERS
192Skin reactionFAERS: 1US FAERS
193Soft Tissue InfectionFAERS: 1US FAERS
194SomnolenceFAERS: 1US FAERS
195Supraventricular tachycardiaFAERS: 1US FAERS
196SwellingFAERS: 1US FAERS
197Therapeutic response unexpectedFAERS: 1US FAERS
198Therapy cessationFAERS: 1US FAERS
199Thermal burnFAERS: 1US FAERS
200ThrombocytopeniaFAERS: 1SIDER
US FAERS
201Thyroid cancer metastaticFAERS: 1US FAERS
202Thyroid cancer stage IVFAERS: 1US FAERS
203ToothacheFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
204Toxicity to various agentsFAERS: 1US FAERS
205UlcerFAERS: 1US FAERS
206VasculitisFAERS: 1US FAERS
207Venous ThrombosisFAERS: 1US FAERS
208Vertebral lesionFAERS: 1US FAERS
209Vocal Cord ParalysisFAERS: 1US FAERS
210Von Willebrand's factor antigen increasedFAERS: 1US FAERS
211XerosisFAERS: 1US FAERS
212furuncleFAERS: 1SIDER
US FAERS
213Adenocarcinoma15596048CTD
214Alanine aminotransferase normalSIDER
215AlopeciaSIDER
216Altered state of consciousnessSIDER
217Amylase increasedSIDER
218AnxietySIDER
219AppendicitisSIDER
220Bipolar DisorderSIDER
221Bipolar I disorderSIDER
222Bladder painSIDER
223Blood magnesium decreasedSIDER
224Blood magnesium increasedSIDER
225Blood potassium increasedSIDER
226BradycardiaSIDER
227BronchitisSIDER
228BronchospasmSIDER
229Ca++ increasedSIDER
230Calcium lowSIDER
231CholecystitisSIDER
232CholelithiasisSIDER
233ChromaturiaSIDER
234ChylothoraxSIDER
235ClonusSIDER
236ConjunctivitisSIDER
237Corneal OpacitySIDER
238Creatinine increasedSIDER
239CystitisSIDER
240CystSIDER
241Depressed Level of ConsciousnessSIDER
242Device occlusionSIDER
243Erythema MultiformeSIDER
244GastritisSIDER
245GastroenteritisSIDER
246Gastrointestinal PainSIDER
247GlaucomaSIDER
248Glucose decreasedSIDER
249Glucose increasedSIDER
250Glucose lowSIDER
251InfestationSIDER
252InfluenzaSIDER
253Joint injurySIDER
254LaryngitisSIDER
255LethargySIDER
256Lung Neoplasms15596048CTD
257Lymphatic Metastasis21350000CTD
258Mg reducedSIDER
259Mg++ increasedSIDER
260NasopharyngitisSIDER
261NeutropeniaSIDER
262Pelvic venous thrombosisSIDER
263PericarditisSIDER
264Pneumatosis intestinalisSIDER
265Posterior reversible encephalopathy syndromeSIDER
266Potassium increasedSIDER
267Potassium lowSIDER
268Protein urine presentSIDER
269Renal ColicSIDER
270Respiratory arrestSIDER
271Serum Amylase IncreasedSIDER
272SinusitisSIDER
273Skin UlcerSIDER
274Stent occlusionSIDER
275Stevens-Johnson Syndrome25811541CTD
SIDER
276Sudden deathSIDER
277TracheitisSIDER
278TremorSIDER
279Ventricular arrhythmiaSIDER
280White blood cell count decreasedSIDER
281nervous system disorderSIDER
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120239

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.